A Federal Court Says Your Prescription Records Aren’t Really Private. The Supreme Court Might Have Something to Say About That.

A Federal Court Says Your Prescription Records Aren’t Really Private. The Supreme Court Might Have Something to Say About That.

https://www.aclu.org/blog/privacy-technology/location-tracking/federal-court-says-your-prescription-records-arent-really

When you fill a prescription at your local drug store, you would surely bristle at someone behind you peeking over your shoulder — but in a decision issued last week, a federal court in Utah said that you have no Fourth Amendment right to object when the peeker is the United States government.

You read that correctly: In a case challenging the Drug Enforcement Administration’s warrantless access to patient prescription records stored in a secure state database, the court relied in part on an outdated legal doctrine to rule that a “patient in Utah decides to trust a prescribing physician with health information to facilitate a diagnosis,” and thereby “takes the risk . . . that his or her information will be conveyed to the government.”

That’s hard to swallow — and it helps make very clear the huge stakes of our upcoming Supreme Court argument in United States v. Carpenter, which concerns the role of the so-called “third-party doctrine” in opening up all kinds of sensitive records to warrantless searches by police.

The 1970s-era doctrine says that Fourth Amendment protections afforded to certain kinds of information disappear once people voluntarily provide that information to a third party. The doctrine emerged from a pair of Supreme Court cases, one of which — Smith v. Maryland — involved a robbery suspect who argued that his Fourth Amendment rights had been violated when police recorded the numbers he dialed from his home phone without obtaining a warrant. The Supreme Court ultimately ruled that because his phone calls passed through the phone company, he lacked a reasonable expectation of privacy in the numbers he dialed, and therefore they weren’t protected by the Constitution.

This case (and its close cousin, United States v. Miller, which held there was no reasonable expectation of privacy in certain banking records held by a bank) is still on the books, and the government has leveraged it to acquire powers that were unimaginable four decades ago. Today, police can track not only the phone numbers dialed by a single suspect over a short period, but also collect reams of information about people — whether their sensitive prescription records or data about their every movement over months at a time — without ever asking a judge for a warrant based on probable cause.

That brings us back to Utah. In 1995, the state passed a law establishing a database for prescriptions of certain medications, including those that treat chronic and acute pain, anxiety disorders, gender transitions, and many more medical conditions or procedures. As of last year, the database housed more than 70 million prescription records and was growing by more than 5 million per year. To address the obvious privacy risks in maintaining this kind of database, and in response to a scandal in which a Utah detective downloaded the entire prescription histories of nearly 500 firefighters, in 2015 the Utah legislature amended its law to require law enforcement to obtain a warrant before retrieving this private medical information.

But even though the amendment made clear that sensitive prescription records should be protected by the safeguards of the warrant requirement — including a probable cause finding of criminal activity, an independent assessment by a judge, and a narrow and particular purpose — the federal government simply didn’t care. In June 2015, the DEA issued a subpoena that was never approved by a judge demanding reams of prescription records from Utah’s state database. When Utah said “get a warrant,” the agency went to court to force the state to turn them over.Last year, the ACLU and the ACLU of Utah intervened in the case on behalf of Equality Utah, an LGBTQ advocacy organization concerned about the privacy of transgender individuals who are prescribed hormones and other medications, and IAFF Local 1696, the union representing Unified Fire Authority firefighters and paramedics who have experienced concrete violations of their prescription privacy in recent years. (We also represent two individual Utahns and the patients and physicians among the ACLU of Utah’s members.)

The ACLU, on behalf of our clients — along with Utah, on behalf of all its residents — argued that the Fourth Amendment required a warrant because people have a reasonable expectation of privacy in their prescription records.

But the court disagreed, deciding that “[p]hysicians and patients do not have a reasonable expectation of privacy in the highly regulated prescription drug industry,” because a patient who gives a doctor private health information takes the risk that her prescribed treatment will be regulated by state law. In other words, because a person gives sensitive information to a third party (here, a doctor and pharmacist!), that person loses an expectation of privacy in that information — the so-called “third-party doctrine.”

While we’ve lost this round in Utah, there’s another on the horizon that may require the court in Utah to reconsider its conclusions. This fall, we’ll be arguing before the Supreme Court in Carpenter that the mere fact that an individual’s private and sensitive records reside with some third party does not, on its own, eliminate the individual’s constitutional right to privacy in those records. In that case, police collected months’ worth of cell phone location information about our client, all without a warrant.

Given how integral cell phones have become to daily life, and the amount of sensitive information they generate about us, it’s simply untenable to argue that the mere act of carrying a cell phone eliminates your Fourth Amendment right against warrantless government access to your most private information. The Carpenter case provides a historic opportunity to ensure that the protections of the Constitution don’t become obsolete in the face of advancing technology. But it’s about more than the privacy of our cell phone location records. It could also provide an opening to give our prescription data and other sensitive records the privacy they deserve. It’s about time.

 

Opioid bill ignores real problem, creates host of new ones, critics argue

https://www.watchdog.org/minnesota/opioid-bill-ignores-real-problem-creates-host-of-new-ones/article_6f73481c-4c18-11e9-bc8c-9b551bb84e55.html

A Minnesota bill seeking to establish an Opioid Stewardship Fund doesn’t address the root cause of the opioid crisis – the illegal sale of narcotics – and will only increase costs to taxpayers, insurance companies and their customers, critics argue. And while well-intentioned, it potentially could drive pharmaceutical companies out of the state, they say.

The bill, HF 400, passed the state House by a vote of 94-34 and awaits action in the Senate. If passed into law, it would create an opioid stewardship fund, an opiate product registration fee, and modify provisions related to opioid addiction prevention, education, intervention, treatment and recovery.

Rep. Tony Albright, Assistant Minority Leader, who voted against the bill, has proposed several alternatives over the years, including better access to treatment and prevention resources.

The fund’s revenue would come from fees on manufacturers and wholesalers of opioid medication. Board members of the Opioid Stewardship Fund would determine fees based on its $20 million annual budget.

But imposing arbitrary fees on pharmaceutical distributors will only increase costs for everyone and do nothing to address the opioid crisis, Grover Norquist, president of Americans for Tax Reform, argues.

HF 400 “could even make the opioid crisis worse,” Norquist says. “The legislation would impose a harmful new tax that would hurt patients in need of medicine by driving up costs directly and causing supply problems that would further hike costs and create access issues.”

Action 4 Liberty, an advocacy group that opposes the bill, argues “government should not get involved in the decision-making of prescribing pain medication from medical professionals.”

The bill dictates how much opioid pain medication a doctor can prescribe to patients who’ve had surgery or undergone a major trauma. It states, “when used for the treatment of acute pain associated with a major trauma or surgical procedure, initial prescriptions for opiate or narcotic pain relievers listed in Schedules II through IV of section 152.02 shall not exceed a seven-day supply.”

The bill also adds mandated acupuncture coverage to Minnesota health insurance plans: “health plans must cover acupuncture services for the treatment of pain and ongoing pain management.”

The new regulations are misplaced and overly burdensome, the Washington, D.C.-based advocacy organization, Citizens Against Government Waste (CAGW), argues.

“Because the opioid crisis is primarily driven by illegal narcotics like fentanyl and heroin, it would be prudent for legislators to focus their efforts on preventing those drugs from being trafficked, instead of placing further regulations and taxes on the legal pharmaceuticals that Americans use every day,” Elizabeth Wright, CAGW’s director of health policy, said.

According to a study published this month by economics professors at Union University in New York, any costs to comply will be passed on to taxpayers. When evaluating a similar opioid tax proposed in New York, the researchers found that “the proposed tax will encourage residents suffering from opioid dependence to switch to cheaper illegal opioids, including heroin and fentanyl, with increased rates of accidental overdose.”

The opioid tax would drive up prices for consumers and insurers, the researchers found, and not actually address the drug-addiction crisis.

None of these initiatives address the root of the opioid problem, critics argue.

Approximately 26,000 people died nationwide from fentanyl sold on the black market originating from China and Mexican cartels in 2017, according to a Bloomberg News report. According to Centers for Disease Control (CDC) data, the sale of illicit fentanyl poses the greatest risk in the opioid crisis.

Critics point out that because the tax demands an arbitrary amount of fees, once one fee-paying pharmaceutical company leaves the state, the rest will end up paying more, and then also might consider leaving. Suppliers would then leave the state, opponents of the bill fear, creating another crisis altogether – less access to medication.

“Taxpayers should make their voices heard and demand that policies related to the opioid epidemic are focused on the cause of the crisis, not on a political scapegoat,” Wright added.

Dr Mark Ibsen : unhappy about how a cancer survivor veteran loosing his pain meds

Under treatment of pain – ELDER ABUSE – plaintiff awarded 1.5 million by jury

http://www.mywhatever.com/cifwriter/library/eperc/fastfact/ff63.html

Title: Fast Fact and Concept #63: The legal liability of undertreatment of pain

Author(s): Warm, Eric; Weissman, David E

It is well recognized that physician’s fear of fear of regulatory scrutiny (DEA, state medical boards), is a major contributor to the problem of under treatment of pain. A recent landmark lawsuit should be a wake-up call for all physicians that this type of practice poses its own legal liability. An 85-year-old California man with metastatic lung carcinoma spent the final week of his life in severe pain. Three years after his death his children sued his doctor alleging that the physician had failed to prescribe drugs powerful enough to relieve their father’s suffering. This was one of the first U.S. cases in which a doctor has gone on trial for allegedly under-treating a patient’s pain. By a 9 to 3 vote the jury decided that the physician’s lack of attention to pain constituted elder abuse, awarding the family $1.5 million (the amount was reduced to $250,000). To win, lawyers convinced the jury that under-treatment of pain was “reckless negligence”. Until recently, lawyers would have considered such a suit un-winnable. Given politically savvy aging baby boomers, as well as the preponderance of sound scientific evidence for the proper assessment and treatment of pain, we can probably expect more such verdicts. Here are some tips for how physicians can better protect themselves from charges of under-treatment of pain?

  • Review your own practice–are you currently meeting JCAHO standards? Find out at: http://www.jcaho.org and AHQR (a.k.a. AHCPR) http://www.ahrq.gov/clinic/cpgarchv.htm pain guidelines?
  • Improve your knowledge and skills in pain assessment and treatment. (Some states, such as California, now require mandatory pain CME).
  • Learn about and utilize your local consultation resources for pain management.
  • Improve your knowledge and skills in assessing substance abuse disorders; learn about and utilize your local resources for substance abuse referrals and treatment.
  • Improve your understanding of the drug regulatory system and how it functions- learn about the common triggers for regulatory review . Go to: http://www.medsch.wisc.edu/painpolicy/ for information about federal and state regulatory laws and regulations.
  • Become active in your hospital pain improvement efforts-check with your hospital QI department and their efforts to meet the new JCAHO pain guidelines.
  • Become active with your state Cancer Pain Initiative; go to http://www.aacpi.org/ to find information about your state activities.

Ideally physicians should not use the fear of lawsuits to help guide medical care, but evidence shows that they do. In a way, this attention on improved pain management may become a silver lining in the black cloud of our litigious society.

References

Stieg RL, et al: Roadblocks to effective pain treatment. Med Clin N Amer, 1999;83(3): 809-821.

Okie, S. Doctor’s Duty to Ease Pain At Issue in Calif. Lawsuit. Washington Post.May 7, 2001; Page A03

Crane M, Treating pain: damned if you don’t? Med Economics, Nov 19, 2001, pp 67-69.

Weissman DE, Doctors, Opioids and the law: The Effect of Drug Regulations on Cancer Pain Management. Semin Oncol 20(Suppl A): 53-58, 1993.

Gilson AM, Joranson DE. Controlled substances and pain management: Changes in knowledge and attitudes of state medical regulators. Journal of Pain and Symptom Management. 2001;21(3):227-237.

Joranson DE, Maurer MA, Gilson AM, Ryan KM, Nischik JA. Annual review of state pain policies, 2000. Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center. Madison, Wisconsin; February 2001.

Jacox A, Carr DB, Payne R, et al. Management of Cancer Pain. Clinical Practice Guideline No. 9 AHCPR Publication No. 94-0592, Rockville, MD. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, 1994.

Acute Pain Management Guideline Panel. Acute pain management: Operative or Medical Procedures and Trauma Clinical Practice Guideline. AHCPR Publication No. 92-0032. Rockville, MD. Agency for Health Care Policy and Research, US Department of Health and Human Services, Public Health Service, 1992.

Copyright and Referencing Information: Users are free to download and distribute Fast Facts for educational purposes only. Citation for referencing. Fast Facts and Concepts #63 The legal liability of undertreatment of pain. Warm E and Weissman DE. March, 2002. End-of-Life Physician Education Resource Center www.eperc.mcw.edu.

Fast Facts and Concepts was originally developed as an end-of-life teaching tool by Eric Warm, MD, U. Cincinnati, Department of Medicine. See: Warm, E. Improving EOL care–internal medicine curriculum project. J Pall Med 1999; 2: 339-340.

Disclaimer: Fast Facts provide educational information, this information is not medical advice. Health care providers should exercise their own independent clinical judgment. Some Fast Fact information cites the use of a product in dosage, for an indication, or in a manner other than that recommended in the product labeling. Accordingly, the official prescribing information should be consulted before any such product is used.

Creation Date: 3/2002

Format: Handouts

Purpose: Instructional Aid, Self-Study Guide, Teaching

Audience(s)

Training: Fellows, 1st/2nd Year Medical Students, 3rd/4th Year Medical Students, PGY1 (Interns), PGY2-6, Physicians in Practice
Specialty: Anesthesiology, Emergency Medicine, Family Medicine, General Internal Medicine, Geriatrics, Hematology/Oncology, Neurology, OB/GYN, Ophthalmology, Pulmonary/Critical Care, Pediatrics, Psychiatry, Surgery
Non-Physician: Nurses

ACGME Competencies: Medical Knowledge

Keyword(s): Addiction, Chronic non-malignant pain, Controlled substance regulations, Pain, Pain assessment, Pain treatment

Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis

Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis

https://jamanetwork.com/journals/jama/article-abstract/2727448

Question  Is tramadol prescription associated with a higher risk of all-cause mortality than other pain relief medications among patients with osteoarthritis?

Findings  In this cohort study that included 88 902 patients with osteoarthritis, initial prescription of tramadol was associated with a significantly increased risk of mortality over 1 year compared with initial prescription of naproxen (hazard ratio [HR], 1.71), diclofenac (HR, 1.88), celecoxib (HR, 1.70), and etoricoxib (HR, 2.04), but not compared with codeine (HR, 0.94).

Meaning  Tramadol prescription may be associated with increased all-cause mortality compared with commonly prescribed nonsteroidal anti-inflammatory drugs, but further research is needed to determine if this relationship is causal.

Abstract

Importance  An American Academy of Orthopaedic Surgeons guideline recommends tramadol for patients with knee osteoarthritis, and an American College of Rheumatology guideline conditionally recommends tramadol as first-line therapy for patients with knee osteoarthritis, along with nonsteroidal anti-inflammatory drugs.

Objective  To examine the association of tramadol prescription with all-cause mortality among patients with osteoarthritis.

Design, Setting, and Participants  Sequential, propensity score–matched cohort study at a general practice in the United Kingdom. Individuals aged at least 50 years with a diagnosis of osteoarthritis in the Health Improvement Network database from January 2000 to December 2015, with follow-up to December 2016.

Exposures  Initial prescription of tramadol (n = 44 451), naproxen (n = 12 397), diclofenac (n = 6512), celecoxib (n = 5674), etoricoxib (n = 2946), or codeine (n = 16 922).

Main Outcomes and Measures  All-cause mortality within 1 year after initial tramadol prescription, compared with 5 other pain relief medications.

Results  After propensity score matching, 88 902 patients were included (mean [SD] age, 70.1 [9.5] years; 61.2% were women). During the 1-year follow-up, 278 deaths (23.5/1000 person-years) occurred in the tramadol cohort and 164 (13.8/1000 person-years) occurred in the naproxen cohort (rate difference, 9.7 deaths/1000 person-years [95% CI, 6.3-13.2]; hazard ratio [HR], 1.71 [95% CI, 1.41-2.07]), and mortality was higher for tramadol compared with diclofenac (36.2/1000 vs 19.2/1000 person-years; HR, 1.88 [95% CI, 1.51-2.35]). Tramadol was also associated with a higher all-cause mortality rate compared with celecoxib (31.2/1000 vs 18.4/1000 person-years; HR, 1.70 [95% CI, 1.33-2.17]) and etoricoxib (25.7/1000 vs 12.8/1000 person-years; HR, 2.04 [95% CI, 1.37-3.03]). No statistically significant difference in all-cause mortality was observed between tramadol and codeine (32.2/1000 vs 34.6/1000 person-years; HR, 0.94 [95% CI, 0.83-1.05]).

Conclusions and Relevance  Among patients aged 50 years and older with osteoarthritis, initial prescription of tramadol was associated with a significantly higher rate of mortality over 1 year of follow-up compared with commonly prescribed nonsteroidal anti-inflammatory drugs, but not compared with codeine. However, these findings may be susceptible to confounding by indication, and further research is needed to determine if this association is causal.

Addiction now defined as brain disorder, not behavior issue

Addiction now defined as brain disorder, not behavior issue

Decades of research convinced American Society of Addiction Medicine to change definition

http://www.nbcnews.com/id/44147493/ns/health-addictions/t/addiction-now-defined-brain-disorder-not-behavior-issue/

Addiction is a chronic brain disorder and not simply a behavior problem involving alcohol, drugs, gambling or sex, experts contend in a new definition of addiction, one that is not solely related to problematic substance abuse.

The American Society of Addiction Medicine (ASAM) just released this new definition of addiction after a four-year process involving more than 80 experts. It is best to click here for the best addiction advice. 

“At its core, addiction isn’t just a social problem or a moral problem or a criminal problem. It’s a brain problem whose behaviors manifest in all these other areas,” said Dr. Michael Miller, past president of ASAM who oversaw the development of the new definition. “Many behaviors driven by addiction are real problems and sometimes criminal acts. But the disease is about brains, not drugs. It’s about underlying neurology, not outward actions.”

The new definition also describes addiction as a primary disease, meaning that it’s not the result of other causes, such as emotional or psychiatric problems. And like cardiovascular disease and diabetes, addiction is recognized as a chronic disease; so it must be treated, managed and monitored over a person’s lifetime, the researchers say.

Two decades of advancements in neuroscience convinced ASAM officials that addiction should be redefined by what’s going on in the brain. For instance, research has shown that addiction affects the brain’s reward circuitry, such that memories of previous experiences with food, sex, alcohol and other drugs trigger cravings and more addictive behaviors. Brain circuitry that governs impulse control and judgment is also altered in the brains of addicts, resulting in the nonsensical pursuit of “rewards,” such as alcohol and other drugs.

A long-standing debate has roiled over whether addicts have a choice over their behaviors, said Dr. Raju Hajela, former president of the Canadian Society of Addiction Medicine and chair of the ASAM committee on addiction’s new definition.

“The disease creates distortions in thinking, feelings and perceptions, which drive people to behave in ways that are not understandable to others around them,” Hajela said in a statement. “Simply put, addiction is not a choice. Addictive behaviors are a manifestation of the disease, not a cause.”

Even so, Hajela pointed out, choice does play a role in getting help.

“Because there is no pill which alone can cure addiction, choosing recovery over unhealthy behaviors is necessary,” Hajela said.

This “choosing recovery” is akin to people with heart disease who may not choose the underlying genetic causes of their heart problems but do need to choose to eat healthier or begin exercising, in addition to medical or surgical interventions, the researchers said.

“So, we have to stop moralizing, blaming, controlling or smirking at the person with the disease of addiction, and start creating opportunities for individuals and families to get help and providing assistance in choosing proper treatment,” Miller said.

5 Secrets Your Doctor Will Never Tell You

5 Secrets Your Doctor Will Never Tell You

The inside scoop only a physician could tell you.

https://www.psychologytoday.com/ca/blog/heal-the-mind-heal-the-body/201903/5-secrets-your-doctor-will-never-tell-you

Medical privacy is very important in medicine and as doctors keep your problems confidential, they often also keep their problems a secret to the outside world.

Here are 5 secrets doctors don’t want to reveal and how knowing about them can protect you:  

Secret # 1:

Doctors often order medical tests, but they sometimes forget to look at the test results or they overlook suspicious details.

An example is Mark who went to see his doctor for a productive cough for the last 3 weeks. His doctor ordered a chest X-Ray to rule out pneumonia.  The radiologist commented that Mark’s lungs were clear, that there was no pneumonia, but he noticed at the bottom of the X-Ray, a suspicious area in Mark’s liver. He recommended an abdominal CT scan. Mark’s doctor only paid attention to the fact that there was no pneumonia and told Mark not to worry.  He gave Mark a treatment of antibiotics which resolved Mark’s cough.  One year later, Mark came in his doctor’s office for abdominal pain.  An abdominal ultrasound revealed a large liver mass which turned out to be a metastasis from colon cancer.  The cancer was too advanced, and Mark couldn’t be saved.  This was unfortunate because Mark’s doctor could have kept Mark alive by reading the lung X-Ray report thoroughly and by ordering an abdominal CT scan one year prior while the liver metastasis was still small and the cancer still treatable.

Similar cases are not infrequent: In 2009, L.P. Casilino (Cornell Medical College in NY) and colleagues found (Archives of Internal Medicine) that after reviewing the medical records of 5434 patients aged 50 to 69, physicians failed to inform patients 7.1% of the time. 

How can you prevent this from happening to you?

Always request a copy of all your reports especially your blood test results and your radiology reports (plain X-Rays, CT scans, MRIs, etc.).  Read the results yourself thoroughly and don’t be shy about asking your doctor questions if something seems abnormal.  If you have any doubt, run the results by another doctor to make sure that all that is abnormal is attended to.

Secret # 2:

Even the best doctor can make a mistake in treatment, prescribing the wrong medication or the wrong dose of the right medication.  This is especially true in hospitals.  

Giampaolo P. Velo of Verona University Hospital in Italy writes in the 2009 British Journal of Clinical Pharmacology that medication errors are common in general practice and in hospitals.  Velo mentions in the article that the range of errors attributable to junior doctors can vary from 2 to 514 per 1000 prescriptions and from 4.2% to 82 % of patients.

Henriksen and colleagues describe that in Denmark in the first 6 months of 2014, there were 147 mistakes in the prescription of anticoagulants (most often the dose was too high).  Out of those 147 mistakes, 7 ended in the death of the patient (who most often bled to death) and 83 gave rise to serious problems.  Henriksen points out that most medications errors happen when there is a hospital admission, a hospital discharge, or surgery. 

How can you prevent a medication mistake from happening to you?

Check with your pharmacist that the medication prescribed by your doctor is for your condition and that the dose prescribed is appropriate, especially if you are just discharged from a hospital.  If you have any doubt, don’t hesitate to give your physician a call or to get a second medical opinion.  

Secret # 3:

Even the best doctor can make a mistake in diagnosis:

Here is an example: Mary went to see her physician for acute diarrhea that had started the week prior.  Her physician diagnosed an infectious gastro-enteritis and gave her Imodium and Cipro.  Despite this treatment, Mary’s diarrhea continued for several weeks, completely debilitating her.  Desperate, Mary searched on the internet for the possible causes of diarrhea. She found that Magnesium could give diarrhea…. And she was taking high doses of Magnesium.  Actually, looking back on what happened, Mary realized that her diarrhea had started just a few days after her first Magnesium intake (which she was taking to decrease her anxiety).  She decided to stop taking Magnesium and within a few days, her diarrhea resolved. Her physician had forgotten to ask her if she was taking any supplements and had made the wrong diagnosis of infectious gastro-enteritis when in fact she was just having a side-effect from the Magnesium she was ingesting.  

Mistakes in diagnosis are common.  Doctors are pressed for time and when they see 30 to 40 patients a day are prone to make mistakes.

How do you prevent a mistake in diagnosis?

When your symptom continues for longer than you think it should, do your own research on the Internet, go back to see your physician and/or seek a second medical opinion. When your body tells you there is something wrong with it, trust what your body says.

Secret # 4:

Some doctors will not know about the latest research or about the best treatment for your condition:

Here is my own example:  The last few months, I have had incredible pain in my right ear when travelling by plane and landing.  I went to see my ENT (Ear, Nose and Throat) physician who diagnosed a Eustachian tube problem and prescribed a steroid nasal spray for every day use.  As the problem didn’t improve and I had to take an average of 4 flights per month (over 44 flights per year) I went to see another ENT who prescribed a high dose of an oral steroid to take before each flight.  This meant that I had to take a high dose of steroid at least 44 days a year with potential serious side effects, such as stomach inflammation, osteoporosis and cataract.  Unsatisfied with that answer, I went to see 3 more ENT in the USA and in Paris, France. Two of them (one in the USA and one in France) confirmed that the best way to resolve my problem was to take a high dose of steroid before each flight, the third physician (in France) recommended that, during landing, I use a little mechanical device invented by another ENT physician.  I ordered that device, which is a pressure equalizer used at the first sign of ear pain when landing.   As soon as I used the new device, my ear pain disappeared.  I had no need for oral steroid with heavy side-effects.  

How can you find the best treatment for your condition?

It is always advisable to get a second or even a third opinion (and in my case, fourth and fifth opinion) if you are not happy with the first one.  It’s impossible for any doctor to know all the latest treatments.  If the treatment you are taking for your condition doesn’t satisfy you completely, look for alternative answers.  Every week new treatments are discovered and approved by the FDA.  Some doctors will know about them, while other won’t.  My advice is to continue exploring options until you are completely satisfied.

Secret # 5: 

A lot of doctors are very stressed out and are sometimes burnt out, depressed and suicidal, which can lead to low professionalism.

Lisa Rotenstein, MD, MBA and colleagues (JAMA September 2018) extracted burnout prevalence data from 182 studies involving 109 628 physicians in 45 countries between 2001 and 2018.  Rotenstein found that 72% of physicians had emotional exhaustion and 67 % had overall burnout.

Maria Panagioti, PhD and Colleagues, published in JAMA Internal Medicine in 2018 a meta-analysis of 47 studies on 42 473 physicians aged 27 to 53 and found that “burn-out is associated with 2-fold increased odds of unsafe care, unprofessional behaviors and low patient satisfaction.”  This link was seen more in residents and in less than 5 years post residency physicians.

Burnout and emotional exhaustion can lead to depression which can lead to suicide especially since physicians have easy access to medications.

Louise B Andrew, MD, JD writes in 2018 that physicians have one of the highest risks of dying from suicide despite having a lower mortality risk from cancer and heart disease relative to the general population.  L. Andrew estimates 300 to 400 suicides by physicians per year, suicide being, after accidents, the most common cause of death among medical students.

How can you stop a burnt-out physician from giving you unsafe care?

Be aware that you only have 10 to 15 minutes with your physician (sometimes only 5 minutes) so be on time for your office visit. Then, tell your physician in one sentence what you are coming in for (this should include when your new symptom started, how fast the symptom got worse and what other symptoms are associated with your malady).  Also come prepared with the names and doses of all the medications you are taking.  If you have questions for the physician, write them down in advance of the appointment.  Preparing thoroughly for each appointment will allow your doctor to be more efficient and consequently to relax, de-stress and take excellent care of you

NACDS lauds bill to mitigate opioid abuse

NACDS lauds bill to mitigate opioid abuse

www.chaindrugreview.com/nacds-lauds-bill-to-mitigate-opioid-abuse/

Legislation limits initial scripts to seven days.

ARLINGTON, Va.— The National Association of Chain Drug Stores Friday welcomed Senate legislation that would limit to a seven-day supply the initial prescriptions of opioids for acute pain —  a move that is consistent with Centers for Disease Control and Prevention’s (CDC) guidelines.

Steve Anderson

Sens. Kirsten Gillibrand (D., N.Y.) and Cory Gardner (R., Colo.) announced the introduction of the legislation, the John S. McCain Opioid Addiction and Prevention Act (S. 724), in a press release quoting NACDS president and CEO Steve Anderson.

“The seven-day limit for initial acute-pain opioid prescriptions is consistent with pharmacists’ recommendations from the front lines of care, their collaboration with law enforcement, and the needs of chronic pain sufferers,” said Anderson. “Six in 10 Americans support this measure, with only two-in-10 indicating opposition, according to a January 2019 Morning Consult poll commissioned by NACDS. This bill will help prevent addiction and help prevent unused medications from falling into the wrong hands. Our support reflects pharmacies’ longstanding commitment to serve as part of the solution.”

NACDS has noted that the opinion research reflects consistent support for this strategic approach across political ideologies, and that support is particularly strong among seniors. Furthermore, seven-in-10 voters support “advancing policies that leverage pharmacies’ role as working partners for stronger and safer communities _  such as working to address the opioid-abuse epidemic.” CDC notes that, for acute pain, “three days or less will often be sufficient; more than seven days will rarely be needed.”

The bill is consistent with one of NACDS’ priority public policy recommendations to help further address the opioid abuse epidemic. NACDS’ recommendations relate to initial prescription limits for acute pain; prescription drug monitoring plans (PDMP); drug disposal; and mandatory electronic prescribing.

The legislation would build on the SUPPORT for Patients and Communities Act (H.R. 6), enacted in 2018, which is consistent with all of NACDS’ recommendations and which was particularly helpful in requiring electronic prescribing for Schedule II through V controlled substances prescriptions covered under Medicare Part D to help prevent fraud, abuse and waste _ with limited exceptions to ensure patient access. The legislation also is consistent with the White House’s 2019 National Drug Control Strategy, which NACDS welcomed in February.

In addition to advancing its public policy recommendations, NACDS and pharmacies maintain longstanding and ongoing initiatives to prevent opioid abuse, including compliance programs; advancing e-prescribing; drug disposal; patient education; security initiatives; fostering naloxone access; stopping illegal online drug-sellers and rogue clinics; and more. NACDS’ Chain Pharmacy Community Engagement Report indicates that opioid abuse prevention stands as one of the top priorities for NACDS members among their community engagement initiatives.

We have all seen/read the “off the rails” proposed bill by Senators Gillibrand and Gardner and here we have the NACDS ( National Association of Chain Drug Stores… STRONGLY endorsing this lame opiate bill that many people will believe will do much harm … especially to those who will be the new chronic pain pts of tomorrow.

NACDS represents the 40, 000 odd chain pharmacies… that is about 60%-70% of all community (retail) pharmacies. Just another reason that pts should start supporting the local independent pharmacies  http://www.ncpanet.org/home/find-your-local-pharmacy  here is a link to find a local independent pharmacy by zip code

We have a serious and dramatically growing pharmacist surplus… it is reported that the 140 odd pharmacy schools are graduating 15,000/yr new pharmacists and the market place is claimed to only have a need for 10,000.  We have 5000 new graduate pharmacists looking for jobs that don’t exist. So these chain pharmacists are typically  being told that unless you do what you are told – by the chain employer – we have a “pile” of pharmacists’ applications that would gladly take their job.

Most of these new graduates have six figure student loans that and after to start repaying these loans at 6-9 months after graduation.

For those of who you say that you are being treated “wonderfully” by the chain store that you patronize, in reality you are only one corporate policy and procedure change or one Rx dept staffing change for everything that has been going wonderfully to GO SOUTH…literally OVERNIGHT.

A drug of abuse that costs society THREE TIMES the cost of the war on drugs and not a crisis ?

Why Alcohol Misuse May Be the Forgotten Addiction

https://www.psychologytoday.com/us/blog/addiction-recovery-101/201812/why-alcohol-misuse-may-be-the-forgotten-addiction

In recent years, Americans have begun, justifiably, to recognize the complex public health problem of opioid misuse and associated overdose deaths as a national crisis. Unfortunately, as is often the case when a tidal wave of worry about a particular health issue engulfs the nation, other similar concerns are often swept out of public consciousness. 

Take alcohol misuse, for instance. Although alcohol arguably presents a greater threat to public health than opioid misuse, it has in many ways been overlooked in the recent national conversation about substance use disorders. 

Alcohol misuse occurs when a person drinks in a manner, situation, amount, or frequency that could cause harm to that individual or those around them. The data and statistics on alcohol misuse paint a clear picture of the continual threat alcohol poses, both in the United States and internationally.

In the U.S. alone, one in 10 deaths among working-age adults are due to alcohol misuse, and more than 88,000 people die from alcohol-related causes each year — making it the third leading preventable cause of death.

Alcohol misuse costs the U.S. nearly $250 billion per year in health care and criminal justice expenditures, lost workplace productivity, and other costs. Meanwhile, in 2016 an estimated 14.6 million American adults had alcohol use disorder.

Alcohol use disorder encompasses a range of symptoms with varying severity, from mild disordered use to addiction. Despite its prevalence and impact, only a fraction of individuals with this disorder seek or receive professional help, and fewer still receive behavioral therapies or medications that have been demonstrated effective through rigorous scientific research. In part this is because patients and their families don’t know the range of treatment options available, and don’t know how to search for treatment providers who offer good-quality care. 

Some might be scared away from seeking help, because they believe that it means having to “go away to rehab” or “quit drinking altogether, forever.” In fact, there is a broad menu of evidence-based treatment options accessible online and in person to facilitate different drinking goal choices and aid in decisions about quality of life, whether it is to reduce alcohol or stop completely. Some individuals will need life-saving, medically supervised “rehab-style” detoxification, stabilization, and to abstain completely. Others may be able to moderate their drinking at home, with the help of family and friends.

bigjom/Adobe
Source: bigjom/Adobe

The point is, finding out more about the variety of available options may surprise many people, and help them begin to consider and make healthier changes regarding their alcohol use.

The National Institute on Alcohol Abuse and Alcoholism (NIAAA), the world’s largest funder of scientific research on the health effects of alcohol, as well as the diagnosis, prevention, and treatment of alcohol misuse, recently released an Alcohol Treatment Navigator. Designed for family members seeking to find care for a loved one with alcohol use disorder, the Navigator spells out what they need to know, and what they need to do, to find good-quality treatment that meets their specific needs. 

The tool highlights five signs of quality to recognize — such as what credentials to look for in a qualified treatment provider and what specific types of counseling they should offer — signs that are consistent with scientific research and expert consensus on what constitutes quality care.

Other national nonprofit organizations, such as Facing Addiction, have also recently released tools to help individuals self-identify potential problems with alcohol use, and to help provide resources for individuals to find local care and treatment.

The more informed consumers are about their treatment options, the more likely they may be to reach out for help, and to have successful outcomes.

Learning to ask questions about treatment providers’ credentials, experience, therapeutic approaches, and costs is imperative regardless of the form of treatment being sought.

For family members, too, there is often a grave and enduring unpredictability that accompanies a loved one’s alcohol problem. There are now evidence-based options that can help partners and family members get the help they need for themselves, as well to help their loved one more effectively (e.g., the Community Reinforcement Approach and Family Training or “CRAFT” model).

While the tragedy of so many opioid overdose deaths continues to grab the headlines, it is easy to forget the many more millions of people and their family members impacted by alcohol use disorder. For these individuals, this disorder — especially in its most severe form, addiction — cannot be forgotten.

Now, more than ever, however, there is an array of evidence-based treatment and recovery support options available — at the click of a mouse, at the end of a phone, or through an office door.

Resolving an alcohol problem, whatever its impact, is very possible; in fact, very probable. Research has shown that most people suffering from an alcohol problem can and do recover. Also, just like many other disorders and diseases, the earlier someone begins to seek help, the shorter the time to remission. The important thing is to get started; do something positive, sooner rather than later.    

Change opiate regulations Emergency C.O.R.E.

cover photo, No photo description available.

There are people who make things happen, those people who watch things happen, & there are those who wonder what happened.

In the face of pain, there are no heroes.
~ George Orwell, 1984

There are people who make things happen, those people who watch things happen, & there are those who wonder what happened

https://videoyourpain.com/

video advocacy campaign project that we are forming. The website is: www.videoyourpain.com and once we get at least 50 to 100 testimonial videos from chronic pain sufferers to send us their 2 minute video testimonials, we are going to launch our COREUSA website and promote it to congressional members and committees, plus governmental organizations and officials plus political parties and leaders, not to mention the general public at large at well. We just need help from our fellow chronic pain sufferers to help promote it. Would this be something that you would be willing to promote? I also know you have a large following of email subscribers to your email newsletter, that would be a great place to help promote it as well.
I would be willing, in turn, to advertise your website and newsletter on the COREUSA website the minute it goes live.
Is this something you would be interested in helping us do?